All News

Obesity Still Plagues the US, But Rates Are Declining in Some States: The Trust for America's Health Report
October 16, 2025

Obesity rates in states where it has leveled at 35% decreased for the first time but report authors warn the progress is limited and at risk due to federal budget cuts.

John Anderson, MD on How to Integrate CGM in Primary Care: "Just Do It"
October 16, 2025

The Frist Clinic clinician said that technical difficulty is not impeding CGM uptake in primary care. "The real limitation is they just haven't done it before."

Multidisciplinary Lung Cancer Screening Program Achieves Screening Rates Above 70%
October 16, 2025

A multidisciplinary lung cancer screening program significantly boosts screening rates, ensuring timely follow-ups and early diagnoses for eligible patients.

The Menopause Society 2025 Annual Meeting: A Primary Care Preview
October 16, 2025

The Menopause Society 2025 Annual Meeting, Oct 21-25, in Orlando, will focus on optimizing women's health and longevity at menopause and beyond. Highlights here.

Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose
October 16, 2025

Your daily dose of the clinical news you may have missed.

Abdominal Aortic Aneurysm Management: From Detection to Referral and Ongoing Surveillance
October 15, 2025

Highlights include size-based surveillance protocols, referral timing, cardiovascular risk reduction, and coordination with vascular surgery.

Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
October 15, 2025

Merck reveals promising phase 3 results for DOR/ISL, showing minimal impact on weight and lipids in adults with suppressed HIV-1.

Benzodiazepine, Antipsychotic Use Linked to Increased Mortality in Hospice Patients With Dementia
October 15, 2025

A study reveals that starting benzodiazepines or antipsychotics in hospice patients with dementia significantly increases 180-day mortality, urging careful prescribing.

Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
October 15, 2025

GLP-1 RAs liraglutide, semaglutide, and dulaglutide showed similar kidney and cardiovascular outcomes more than 20,000 US veterans with type 2 diabetes.

Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
October 15, 2025

Topline phase 3 data shows oral GLP-1 cuts HbA1c by 2.1% when added to basal insulin, nearly triple placebo's effect in patients poorly controlled on current therapy.